Evidence mapPaperPMID 33435282Full record

ReviewAntioxidants (Basel, Switzerland)2021

Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery.

Jinjoo Lee, Seungjin Noh, Suhyun Lim, Bonglee Kim

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Effect of boswellia (Frontiers in clinical diabetes and healthcare · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. A Combined Probiotic-International journal of molecular sciences · 2026
    Article
  7. Article
  8. Unlocking theMolecules (Basel, Switzerland) · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Timbe (Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  14. Article
  15. The Effects of the Ethanol Extract ofJournal of experimental pharmacology · 2025
    Article
  16. Composition, Anti-Diabetic, and Antioxidant Potential ofMolecules (Basel, Switzerland) · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jinjoo LeeCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.
Seungjin NohCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.
Suhyun LimCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.
Bonglee KimCollege of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.ORCID 0000-0002-8678-156X
Kyung Hee University · KR

Funding

a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea HB20C0038a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea HF20C0116Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education NRF-2020R1I1A2066868the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) No. 2020R1A5A201941311
6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is one of the largest public health problems worldwide. Insulin resistance-related metabolic dysfunction and chronic hyperglycemia result in devastating complications and poor prognosis. Even though there are many conventional drugs such as metformin (MET), Thiazolidinediones (TZDs), sulfonylureas (SUF), dipeptidyl peptidase 4 (DPP-4) inhibitors, glucagon like peptide 1 (GLP-1) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors, side effects still exist. As numerous plant extracts with antidiabetic effects have been widely reported, they have the potential to be a great therapeutic agent for type 2 diabetes with less side effects. In this study, sixty-five recent studies regarding plant extracts that alleviate type 2 diabetes were reviewed. Plant extracts regulated blood glucose through the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway. The anti-inflammatory and antioxidant properties of plant extracts suppressed c-Jun amino terminal kinase (JNK) and nuclear factor kappa B (NF-κB) pathways, which induce insulin resistance. Lipogenesis and fatty acid oxidation, which are also associated with insulin resistance, are regulated by AMP-activated protein kinase (AMPK) activation. This review focuses on discovering plant extracts that alleviate type 2 diabetes and exploring its therapeutic mechanisms.

Indexed as

antioxidantdiabetes mellitusglucose transportinflammationlipid metabolismplant extracts

Identifiers

PMID33435282
PMCPMC7827314
OpenAlexW3118777720

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.